Metadata
| Item Type: | Article |
|---|---|
| Authors/Creators: |
|
| Commentary on: | Palmieri, C, Stein, RC, Liu, X et al. (12 more authors) (2017) IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients. Breast Cancer Research and Treatment, 165 (2). pp. 343-353. ISSN 0167-6806 |
| Copyright, Publisher and Additional Information: | © Springer Science+Business Media, LLC 2017. |
| Dates: |
|
| Institution: | The University of Leeds |
| Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) |
| Depositing User: | Symplectic Publications |
| Date Deposited: | 23 Jan 2018 12:12 |
| Last Modified: | 26 Jul 2018 13:05 |
| Status: | Published |
| Publisher: | Springer Verlag |
| Identification Number: | 10.1007/s10549-017-4539-3 |
| Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:126506 |
Commentary/Response Threads
- Palmieri, C, Stein, RC, Liu, X, Hudson, E, Nicholas, H, Sasano, H, Guestini, F, Holcombe, C, Barrett, S, Kenny, L, Reed, S, Lim, A, Hayward, L, Howell, S and Coombes, RC IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients. (deposited 23 Jan 2018 12:00)
CORE (COnnecting REpositories)
CORE (COnnecting REpositories)